Drawing for ANGIOBLAST SYSTEMS

USPTO serial 79016664

ANGIOBLAST SYSTEMS

Reviewed by CopyMark Law Group

Reg. 3423042Status 404
Filing date
Status date
Registration date
May 6, 2008
Examiner
IN, SUNG HYUN
Law office
PUBLICATION AND ISSUE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with ANGIOBLAST SYSTEMS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; veterinary preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; biotechnology preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; medical preparations for the prevention, management, diagnosis and treatment of connective tissue and musco-skeletal disorders and indications; diagnostic preparations and reagents for medical purposes; culture fluids, namely, cultures of micro-organisms for medical purposes; human allograft tissue; animal allograft tissue; human tissue and animal tissue for transplantation or implantation, medical and surgical purposes; human cells including stem cells, animal cells including stem cells for medical or clinical use; pharmaceutical preparations for the treatment, reconstruction and repair of tissueSECTION 71 - CANCELLED—
042Scientific, research, clinical research, development, advisory and consultancy services in relation to T-cell production, T-cell immunotherapy, cell culture devices, tissue engineering for cellular applications for humans and animals, stem cell banking, tissue banking, drug discovery, vaccine screening, cell culture methods, cell expansion technology including stem cell expansion technology, cellular therapies including stem cell therapies and cellular transplantsSECTION 71 - CANCELLED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 23, 2015DENCNOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED—
Oct 23, 2015DETHDEATH OF INTERNATIONAL REGISTRATION—
Sep 24, 2015INNTTOTAL INVALIDATION PROCESSED BY THE IB—
Sep 2, 2015INTSTOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB—
Sep 2, 2015INPCINVALIDATION PROCESSED—
Aug 12, 2015INTRTOTAL INVALIDATION OF REG EXT PROTECTION CREATED—
Dec 12, 2014C71TCANCELLED SECTION 71—
Nov 29, 2013NREPNEW REPRESENTATIVE AT IB RECEIVED—
Dec 21, 2012FINOFINAL DECISION TRANSACTION PROCESSED BY IB—
Jan 26, 2012ADCHCHANGE OF NAME/ADDRESS REC'D FROM IB—
Aug 22, 2008FICSFINAL DISPOSITION NOTICE SENT TO IB—
Aug 22, 2008FIMPFINAL DISPOSITION PROCESSED—
Aug 6, 2008FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB—
May 6, 2008EXPTEXPARTE APPEAL TERMINATED—
May 6, 2008R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Feb 19, 2008PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Jan 30, 2008NPUBNOTICE OF PUBLICATION—
Jan 16, 2008PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Jan 11, 2008CNEAEXAMINERS AMENDMENT MAILED—
Jan 11, 2008CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Jan 11, 2008XAECEXAMINER'S AMENDMENT ENTERED—
Jan 11, 2008CNEAEXAMINERS AMENDMENT -WRITTEN—
Jan 11, 2008ZZZXPREVIOUS ALLOWANCE COUNT WITHDRAWN—
Dec 14, 2007PBCRWITHDRAWN FROM PUB - OG REVIEW QUERY—
Dec 3, 2007PREVLAW OFFICE PUBLICATION REVIEW COMPLETED—
Dec 3, 2007ALIEASSIGNED TO LIE—
Dec 3, 2007CNEAEXAMINERS AMENDMENT MAILED—
Nov 30, 2007CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Nov 30, 2007XAECEXAMINER'S AMENDMENT ENTERED—
Nov 30, 2007CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 16, 2007TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Sep 27, 2007RECDACTION DENYING REQ FOR RECON MAILED—
Sep 27, 2007CNCFACTION CONTINUING FINAL - COMPLETED—
Aug 9, 2007MAILPAPER RECEIVED—
Aug 9, 2007EXPIEX PARTE APPEAL-INSTITUTED—
Aug 9, 2007JURTJURISDICTION RESTORED TO EXAMINING ATTORNEY—
Aug 9, 2007EXAFEXPARTE APPEAL RECEIVED AT TTAB—
Jul 12, 2007OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB—
Jun 28, 2007OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Jun 28, 2007OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB—
Feb 12, 2007CNFRFINAL REFUSAL MAILEDA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Feb 11, 2007CNFRFINAL REFUSAL WRITTENA final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon.
Jan 20, 2007ACECAMENDMENT FROM APPLICANT ENTERED—
Jan 20, 2007CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jan 20, 2007ALIEASSIGNED TO LIE—
Dec 20, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 3, 2006CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 30, 2006CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 9, 2006TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
May 23, 2006CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
May 23, 2006TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 26, 2006CRCVCORRECTION TRANSACTION RECEIVED FROM IB—
Dec 9, 2005RFNTREFUSAL PROCESSED BY IB—
Nov 23, 2005RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB—
Nov 22, 2005RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW—
Nov 21, 2005CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Nov 18, 2005DOCKASSIGNED TO EXAMINER—
Nov 18, 2005NWAPNEW APPLICATION ENTERED—
Nov 17, 2005REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance